Sheng Feng, Ph.D. （冯胜）

Dr. Sheng Feng has a bachelor’s degree in molecular biology from the University of Science and Technology of China and a Ph.D. in Statistics and Bioinformatics from North Carolina State University. His academic research focused on statistical methods and bioinformatic algorithms in precision medicine and real-world-data (RWD). Since 2012, Dr. Feng has been in the pharmaceutical industry, leading studies in precision medicine, biomarker and RWD at Biogen, AbbVie and Parexel. During the COVID-19 pandemic, Dr. Feng became an advocator and practitioner to leverage RWD in assisting clinical trial designs.